832 related articles for article (PubMed ID: 21306831)
1. Neuro-chemical activation of brain reward meso-limbic circuitry is associated with relapse prevention and drug hunger: a hypothesis.
Blum K; Gold MS
Med Hypotheses; 2011 Apr; 76(4):576-84. PubMed ID: 21306831
[TBL] [Abstract][Full Text] [Related]
2. Neurogenetics of dopaminergic receptor supersensitivity in activation of brain reward circuitry and relapse: proposing "deprivation-amplification relapse therapy" (DART).
Blum K; Chen TJ; Downs BW; Bowirrat A; Waite RL; Braverman ER; Madigan M; Oscar-Berman M; DiNubile N; Stice E; Giordano J; Morse S; Gold M
Postgrad Med; 2009 Nov; 121(6):176-96. PubMed ID: 19940429
[TBL] [Abstract][Full Text] [Related]
3. Overcoming qEEG abnormalities and reward gene deficits during protracted abstinence in male psychostimulant and polydrug abusers utilizing putative dopamine D₂ agonist therapy: part 2.
Blum K; Chen TJ; Morse S; Giordano J; Chen AL; Thompson J; Allen C; Smolen A; Lubar J; Stice E; Downs BW; Waite RL; Madigan MA; Kerner M; Fornari F; Braverman ER
Postgrad Med; 2010 Nov; 122(6):214-26. PubMed ID: 21084796
[TBL] [Abstract][Full Text] [Related]
4. Manipulation of catechol-O-methyl-transferase (COMT) activity to influence the attenuation of substance seeking behavior, a subtype of Reward Deficiency Syndrome (RDS), is dependent upon gene polymorphisms: a hypothesis.
Blum K; Chen TJ; Meshkin B; Waite RL; Downs BW; Blum SH; Mengucci JF; Arcuri V; Braverman ER; Palomo T
Med Hypotheses; 2007; 69(5):1054-60. PubMed ID: 17467918
[TBL] [Abstract][Full Text] [Related]
5. A Shared Molecular and Genetic Basis for Food and Drug Addiction: Overcoming Hypodopaminergic Trait/State by Incorporating Dopamine Agonistic Therapy in Psychiatry.
Gold MS; Badgaiyan RD; Blum K
Psychiatr Clin North Am; 2015 Sep; 38(3):419-62. PubMed ID: 26300032
[TBL] [Abstract][Full Text] [Related]
6. Drug abuse relapse rates linked to level of education: can we repair hypodopaminergic-induced cognitive decline with nutrient therapy?
Blum K; Schoenthaler SJ; Oscar-Berman M; Giordano J; Madigan MA; Braverman ER; Han D
Phys Sportsmed; 2014 May; 42(2):130-45. PubMed ID: 24875980
[TBL] [Abstract][Full Text] [Related]
7. Addiction and brain reward and antireward pathways.
Gardner EL
Adv Psychosom Med; 2011; 30():22-60. PubMed ID: 21508625
[TBL] [Abstract][Full Text] [Related]
8. Neurogenetics and clinical evidence for the putative activation of the brain reward circuitry by a neuroadaptagen: proposing an addiction candidate gene panel map.
Chen TJ; Blum K; Chen AL; Bowirrat A; Downs WB; Madigan MA; Waite RL; Bailey JA; Kerner M; Yeldandi S; Majmundar N; Giordano J; Morse S; Miller D; Fornari F; Braverman ER
J Psychoactive Drugs; 2011; 43(2):108-27. PubMed ID: 21858957
[TBL] [Abstract][Full Text] [Related]
9. Acute intravenous synaptamine complex variant KB220™ "normalizes" neurological dysregulation in patients during protracted abstinence from alcohol and opiates as observed using quantitative electroencephalographic and genetic analysis for reward polymorphisms: part 1, pilot study with 2 case reports.
Miller DK; Bowirrat A; Manka M; Miller M; Stokes S; Manka D; Allen C; Gant C; Downs BW; Smolen A; Stevens E; Yeldandi S; Blum K
Postgrad Med; 2010 Nov; 122(6):188-213. PubMed ID: 21084795
[TBL] [Abstract][Full Text] [Related]
10. Activation instead of blocking mesolimbic dopaminergic reward circuitry is a preferred modality in the long term treatment of reward deficiency syndrome (RDS): a commentary.
Blum K; Chen AL; Chen TJ; Braverman ER; Reinking J; Blum SH; Cassel K; Downs BW; Waite RL; Williams L; Prihoda TJ; Kerner MM; Palomo T; Comings DE; Tung H; Rhoades P; Oscar-Berman M
Theor Biol Med Model; 2008 Nov; 5():24. PubMed ID: 19014506
[TBL] [Abstract][Full Text] [Related]
11. [Posttraumatic stress disorder (PTSD) as a consequence of the interaction between an individual genetic susceptibility, a traumatogenic event and a social context].
Auxéméry Y
Encephale; 2012 Oct; 38(5):373-80. PubMed ID: 23062450
[TBL] [Abstract][Full Text] [Related]
12. Drug addiction. Part II. Neurobiology of addiction.
Vetulani J
Pol J Pharmacol; 2001; 53(4):303-17. PubMed ID: 11990077
[TBL] [Abstract][Full Text] [Related]
13. Hypodopaminergia and "Precision Behavioral Management" (PBM): It is a Generational Family Affair.
Fried L; Modestino EJ; Siwicki D; Lott L; Thanos PK; Baron D; Badgaiyan RD; Ponce JV; Giordano J; Downs WB; Gondré-Lewis MC; Bruce S; Braverman ER; Boyett B; Blum K
Curr Pharm Biotechnol; 2020; 21(6):528-541. PubMed ID: 31820688
[TBL] [Abstract][Full Text] [Related]
14. Reward deficiency syndrome: genetic aspects of behavioral disorders.
Comings DE; Blum K
Prog Brain Res; 2000; 126():325-41. PubMed ID: 11105655
[TBL] [Abstract][Full Text] [Related]
15. Do dopaminergic gene polymorphisms affect mesolimbic reward activation of music listening response? Therapeutic impact on Reward Deficiency Syndrome (RDS).
Blum K; Chen TJ; Chen AL; Madigan M; Downs BW; Waite RL; Braverman ER; Kerner M; Bowirrat A; Giordano J; Henshaw H; Gold MS
Med Hypotheses; 2010 Mar; 74(3):513-20. PubMed ID: 19914781
[TBL] [Abstract][Full Text] [Related]
16. Involvement of the brain histaminergic system in addiction and addiction-related behaviors: a comprehensive review with emphasis on the potential therapeutic use of histaminergic compounds in drug dependence.
Brabant C; Alleva L; Quertemont E; Tirelli E
Prog Neurobiol; 2010 Nov; 92(3):421-41. PubMed ID: 20638439
[TBL] [Abstract][Full Text] [Related]
17. Neural substrates of drug craving and relapse in drug addiction.
Self DW
Ann Med; 1998 Aug; 30(4):379-89. PubMed ID: 9783837
[TBL] [Abstract][Full Text] [Related]
18. The nicotinic acetylcholine receptor partial agonist varenicline and the treatment of drug dependence: a review.
Crunelle CL; Miller ML; Booij J; van den Brink W
Eur Neuropsychopharmacol; 2010 Feb; 20(2):69-79. PubMed ID: 19959340
[TBL] [Abstract][Full Text] [Related]
19. Dopamine and drug addiction: the nucleus accumbens shell connection.
Di Chiara G; Bassareo V; Fenu S; De Luca MA; Spina L; Cadoni C; Acquas E; Carboni E; Valentini V; Lecca D
Neuropharmacology; 2004; 47 Suppl 1():227-41. PubMed ID: 15464140
[TBL] [Abstract][Full Text] [Related]
20. A review of addiction.
Clay SW; Allen J; Parran T
Postgrad Med; 2008 Jul; 120(2):E01-7. PubMed ID: 18654058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]